Skip to main content
Discovering the causes of cancer and the means of prevention

Thomas R. O'Brien, M.D., M.P.H.

Senior Investigator
Division of Cancer Epidemiology & Genetics

NCI Shady Grove | Room 6E108



Dr. O'Brien received undergraduate and medical degrees from the University of Michigan, and an M.P.H. from the Harvard School of Public Health. He was an Epidemic Intelligence Service Officer and Medical Epidemiologist with the Centers for Disease Control and Prevention before joining the NIH Intramural Research Program in 1992. His primary research interests have involved studies on the transmission and natural history of oncogenic viruses, including human immunodeficiency virus type 1, hepatitis B virus and hepatitis C virus (HCV).

Research Interests

Dr. O’Brien’s research program targets viruses that cause cancer, especially hepatitis C virus, through interdisciplinary studies that emphasize human genetics. He focuses on studies that may translate into clinical or public health benefits. Dr. O’Brien organized a trans-disciplinary group of investigators to refine understanding of the genetic basis for spontaneous HCV clearance and response to treatment for chronic hepatitis C. This collaboration led to the discovery of interferon lambda 4 (IFNL4), a novel gene that appears to underlie observed differences in HCV clearance (Prokunina-Olsson et al, Nature Genetics, 2013). His current work focuses on hepatitis viruses, hepatocellular carcinoma and phenotypic expressions of the IFNL4 genotype.

Press Contacts

To request an interview with NCI researchers, contact the NCI Office of Media Relations. | 240-760-6600